These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8177315)

  • 1. Immunology. Making class II presentable.
    Schmid SL; Jackson MR
    Nature; 1994 May; 369(6476):103-4. PubMed ID: 8177315
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell biology of antigen presentation by B cells.
    Pernis B; Weber DA
    Contrib Microbiol Immunol; 1989; 11():27-42. PubMed ID: 2555111
    [No Abstract]   [Full Text] [Related]  

  • 3. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
    Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
    Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes.
    Amigorena S; Drake JR; Webster P; Mellman I
    Nature; 1994 May; 369(6476):113-20. PubMed ID: 8177316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
    Grant CF; Ali R; Povey S; Stockinger B
    Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen processing and presentation.
    Safley SA; Ziegler HK
    Immunol Ser; 1994; 60():115-30. PubMed ID: 8251564
    [No Abstract]   [Full Text] [Related]  

  • 9. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intercellular exchange of class II major histocompatibility complex/peptide complexes is a conserved process that requires activation of T cells but is constitutive in other types of antigen presenting cell.
    Patel DM; Mannie MD
    Cell Immunol; 2001 Dec; 214(2):165-72. PubMed ID: 12088415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
    Cheng PC; Steele CR; Gu L; Song W; Pierce SK
    J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses.
    Dongre AR; Kovats S; deRoos P; McCormack AL; Nakagawa T; Paharkova-Vatchkova V; Eng J; Caldwell H; Yates JR; Rudensky AY
    Eur J Immunol; 2001 May; 31(5):1485-94. PubMed ID: 11465105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen processing--from cell biology to molecular interactions.
    Gerlier D; Rabourdin-Combe C
    Immunol Today; 1989 Jan; 10(1):3-5. PubMed ID: 2665770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes.
    Lanzavecchia A
    Annu Rev Immunol; 1990; 8():773-93. PubMed ID: 2188679
    [No Abstract]   [Full Text] [Related]  

  • 17. Activated T hybridomas induce upregulation of B7-1 on bystander B lymphoma cells by a contact-dependent interaction utilizing CD40 ligand.
    Jones KW; Hackett CJ
    Cell Immunol; 1996 Nov; 174(1):42-53. PubMed ID: 8929453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class II-mediated T cell response to DNA.
    Waisman A; Zisman E; Mozes E
    Cell Immunol; 1996 Oct; 173(1):7-14. PubMed ID: 8871596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells.
    West MA; Lucocq JM; Watts C
    Nature; 1994 May; 369(6476):147-51. PubMed ID: 8177319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.